Johnson & Johnson (FRA:JNJ)
165.68
+0.40 (0.24%)
Last updated: Oct 21, 2025, 4:15 PM CET
Johnson & Johnson Employees
Johnson & Johnson had 138,100 employees as of December 29, 2024. The number of employees increased by 6,200 or 4.70% compared to the previous year.
Employees
138,100
Change (1Y)
6,200
Growth (1Y)
4.70%
Revenue / Employee
€568,708
Profits / Employee
€155,025
Market Cap
400.01B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 29, 2024 | 138,100 | 6,200 | 4.70% |
Dec 31, 2023 | 131,900 | -20,800 | -13.62% |
Jan 1, 2023 | 152,700 | 11,000 | 7.76% |
Jan 2, 2022 | 141,700 | 7,200 | 5.35% |
Jan 3, 2021 | 134,500 | 2,300 | 1.74% |
Dec 29, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jan 1, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jan 3, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
Siemens Aktiengesellschaft | 327,000 |
Deutsche Telekom AG | 198,194 |
Mercedes-Benz Group AG | 175,264 |
Bayerische Motoren Werke Aktiengesellschaft | 159,104 |
Allianz SE | 156,626 |
SAP SE | 109,121 |
Siemens Energy AG | 98,000 |
Deutsche Bank Aktiengesellschaft | 89,753 |
Johnson & Johnson News
- 2 days ago - Johnson & Johnson (JNJ) Reports Promising Results for Amivantamab in Cancer Study - GuruFocus
- 2 days ago - Johnson & Johnson (JNJ) Boosts Guidance Amid Strategic Unit Separation - GuruFocus
- 2 days ago - Subcutaneous amivantamab delivers promising 45 percent overall response rate with median duration of 7.2 months in recurrent or metastatic head and neck cancer - PRNewsWire
- 4 days ago - Should You Buy, Sell or Hold J&J Stock After Robust Q3 Earnings? - Nasdaq
- 4 days ago - Dividend Roundup: Citigroup, Johnson & Johnson, Caterpillar, Procter & Gamble, and more - Seeking Alpha
- 4 days ago - Johnson & Johnson lawsuit explained: Families sue over baby powder cancer claims - Evening Standard
- 5 days ago - Johnson & Johnson (JNJ) Faces Legal Challenges in UK Over Talc Products - GuruFocus
- 5 days ago - Johnson & Johnson (JNJ) Faces Legal Challenges Over Alleged Asbestos in Baby Powder - GuruFocus